Yahoo Japan and Alphabet-backed Fractyl aims to make one of its proposed products a cornerstone therapy for type 2 diabetes, and has now raised about $270m in total.
Fractyl Health, the US-based metabolic disease treatment developer backed by internet company Yahoo Japan and internet technology group Alphabet, has completed a $100m series F round.
The round was co-led by hedge fund Maverick Capital, healthcare-focused fund M28 Capital and investment firm Population Health Partners, while unspecified new and existing backers also took part.
Founded in 2010, Fractyl is focused on developing treatments for patients with metabolic diseases, including Revita DMR, a non-surgical, endoscopic procedure for the treatment of type…
